Some cannabis compounds can block COVID-19 infection, study finds

A study published this week showed that certain cannabis compounds can prevent COVID-19 infection by blocking the virus from entering cells.

A report on the study, “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants,” published on Monday in The Journal of Natural Medicine, concluded that two cannabinoid acids commonly found in hemp can bind to the spike protein of the SARS-CoV-2, preventing it from entering into the cells and stopping COVID-19 infection.

The acids, cannabigerolic acid, or CBGA, and cannabidiolic acid, known as CBDA, are “Orally bioavailable and with a long history of safe human use,” reads the report. It continues, “…these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2.” 

The lead researcher, Richard van Breemen, explained in a statement this week, “That means cell entry inhibitors, like the acids from hemp, could be used to prevent SARS-CoV-2 infection and also to shorten infections by preventing virus particles from infecting human cells. They bind to the spike proteins so those proteins can’t bind to the ACE2 enzyme, which is abundant on the outer membrane of endothelial cells in the lungs and other organs.” 

Hemp is already used in a wide variety of products, including medicine, supplements, cosmetics, and livestock feed. Hemp also has a good safety profile for human use, said van Breemen.




The following two tabs change content below.
Laura is a freelance writer out of Maryland and a mom of three. Her background is in political science and international relations, and she has been doing political writing and editing for 17 years. Laura has also written parenting pieces for the Today Show and is currently working on writing a collection of remarkable true stories about normal people. She writes for FBA because unbiased news is vital to unity, and readers deserve the facts free of opinion.

Leave a Reply